News & Updates
Showing Gastroenterology articles
Showing
Show Multimedia Only

Real-world study supports new therapeutics for BRAF-mutant metastatic CRC
07 Sep 2026
byAudrey Abella
A real-world study presented at ESMO GI 2026 shows that pembrolizumab immunotherapy and a combination regimen of encorafenib and cetuximab are associated with meaningful survival benefits in BRAF-mutant metastatic colorectal cancer (CRC).
07 Sep 2026

When to resume antithrombotic therapy after GIB?
31 Aug 2026
byChristina Lau
Early resumption of antiplatelet therapy (APT) and anticoagulant therapy (ACT) ≤7 days after gastrointestinal bleeding (GIB) offers a favourable benefit–risk balance in patients with cardiovascular (CV) or cerebrovascular indications, according to a systematic review and meta-analysis conducted by researchers from the Chinese University of Hong Kong and Nanyang Technological University in Singapore.
31 Aug 2026






